{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:15:25Z","timestamp":1794860125634,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NINDS R01NS106008"],"award-info":[{"award-number":["NINDS R01NS106008"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-15-1-0046"],"award-info":[{"award-number":["HDTRA1-15-1-0046"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R61HL154252"],"award-info":[{"award-number":["R61HL154252"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is an inherited neurodegenerative disease caused by expansion of cytosine\u2013adenine\u2013guanine (CAG) repeats in the huntingtin gene, which leads to neuronal loss and decline in cognitive and motor function. Increasing evidence suggests that blood\u2013brain barrier (BBB) dysfunction may contribute to progression of the disease. Studies in animal models<jats:italic>, <\/jats:italic>in vitro models, and post-mortem tissue find that disease progression is associated with increased microvascular density, altered cerebral blood flow, and loss of paracellular and transcellular barrier function. Here, we report on changes in BBB phenotype due to expansion of CAG repeats using an isogenic pair of induced pluripotent stem cells (iPSCs) differentiated into brain microvascular endothelial-like cells (iBMECs). We show that CAG expansion associated with juvenile HD alters the trajectory of iBMEC differentiation, producing cells with\u2009~\u2009two-fold lower percentage of adherent endothelial cells. CAG expansion is associated with diminished transendothelial electrical resistance and reduced tight junction protein expression, but no significant changes in paracellular permeability. While mutant huntingtin protein (mHTT) aggregates were not observed in HD iBMECs, widespread transcriptional dysregulation was observed in iBMECs compared to iPSCs. In addition, CAG expansion in iBMECs results in distinct responses to pathological and therapeutic perturbations including angiogenic factors, oxidative stress, and osmotic stress. In a tissue-engineered BBB model, iBMECs show subtle changes in phenotype, including differences in cell turnover and immune cell adhesion. Our results further support that CAG expansion in BMECs contributes to BBB dysfunction during HD.<\/jats:p>","DOI":"10.1186\/s12987-022-00347-7","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T07:02:53Z","timestamp":1656572573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington\u2019s disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Raleigh M.","family":"Linville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e F.","family":"Nerenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Grifno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Searson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"347_CR1","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"347_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev. 2010;90(3):905\u201381.","journal-title":"Physiol Rev"},{"issue":"2","key":"347_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagace M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W, St-Amour I, Mason SL, Calon F, Lacroix S, Gowland PA, Francis ST, Barker RA, Cicchetti F. Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol. 2015;78(2):160\u201377.","journal-title":"Ann Neurol"},{"key":"347_CR4","doi-asserted-by":"publisher","first-page":"41316","DOI":"10.1038\/srep41316","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Amico E, Scalabri F, Pepe G, Castaldo S, Elifani F, Capocci L, De Sanctis C, Comerci L, Pompeo F, D\u2019Esposito M, Filosa S, Crispi S, Maglione V. Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease. Sci Rep. 2017;7:41316.","journal-title":"Sci Rep"},{"issue":"7","key":"347_CR5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","volume":"19","author":"RG Lim","year":"2017","unstructured":"Lim RG, Quan C, Reyes-Ortiz AM, Lutz SE, Kedaigle AJ, Gipson TA, Wu J, Vatine GD, Stocksdale J, Casale MS, Svendsen CN, Fraenkel E, Housman DE, Agalliu D, Thompson LM. Huntington\u2019s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits. Cell Rep. 2017;19(7):1365\u201377.","journal-title":"Cell Rep"},{"issue":"1","key":"347_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12987-019-0139-4","volume":"16","author":"ME Katt","year":"2019","unstructured":"Katt ME, Mayo LN, Ellis SE, Mahairaki V, Rothstein JD, Cheng L, Searson PC. The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model. Fluids Barriers CNS. 2019;16(1):20.","journal-title":"Fluids Barriers CNS"},{"key":"347_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","volume":"250","author":"CY Lin","year":"2013","unstructured":"Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, Hsiao HY, Chen CC, Chern Y, Chang C. Neurovascular abnormalities in humans and mice with Huntington\u2019s disease. Exp Neurol. 2013;250:20\u201330.","journal-title":"Exp Neurol"},{"issue":"2","key":"347_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.24428","volume":"78","author":"HY Hsiao","year":"2015","unstructured":"Hsiao HY, Chen YC, Huang CH, Chen CC, Hsu YH, Chen HM, Chiu FL, Kuo HC, Chang C, Chern Y. Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann Neurol. 2015;78(2):178\u201392.","journal-title":"Ann Neurol"},{"issue":"2","key":"347_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuroimage.2011.08.112","volume":"59","author":"JJ Chen","year":"2012","unstructured":"Chen JJ, Salat DH, Rosas HD. Complex relationships between cerebral blood flow and brain atrophy in early Huntington\u2019s disease. Neuroimage. 2012;59(2):1043\u201351.","journal-title":"Neuroimage"},{"issue":"19","key":"347_CR10","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","volume":"32","author":"E Cepeda-Prado","year":"2012","unstructured":"Cepeda-Prado E, Popp S, Khan U, Stefanov D, Rodriguez J, Menalled LB, Dow-Edwards D, Small SA, Moreno H. R6\/2 Huntington\u2019s disease mice develop early and progressive abnormal brain metabolism and seizures. J Neurosci. 2012;32(19):6456\u201367.","journal-title":"J Neurosci"},{"issue":"6505","key":"347_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.aax3338","volume":"369","author":"M Barnat","year":"2020","unstructured":"Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, Kassem R, Lenoir S, Agasse F, Braz BY, Liu JP, Ighil J, Tessier A, Zeitlin SO, Duyckaerts C, Dommergues M, Durr A, Humbert S. Huntington\u2019s disease alters human neurodevelopment. Science. 2020;369(6505):787\u201393.","journal-title":"Science"},{"issue":"3","key":"347_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B, Yoon SI, Huang Y, Ooi J, Utami KH, Ziaei A, Ng B, Radulescu C, Low D, Ng AYJ, Loh M, Venkatesh B, Ginhoux F, Augustine GJ, Pouladi MA. Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep. 2017;8(3):619\u201333.","journal-title":"Stem Cell Rep"},{"key":"347_CR13","doi-asserted-by":"crossref","unstructured":"E.T. Strassler, K. Aalto-Setala, M. Kiamehr, U. Landmesser, N. Krankel, Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality, Front Cardiovasc Med 5 (2018).","DOI":"10.3389\/fcvm.2018.00004"},{"issue":"1","key":"347_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nbt.3749","volume":"35","author":"V Lo Sardo","year":"2017","unstructured":"Lo Sardo V, Ferguson W, Erikson GA, Topol EJ, Baldwin KK, Torkamani A. Influence of donor age on induced pluripotent stem cells. Nat Biotechnol. 2017;35(1):69\u201374.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"347_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152105","volume":"11","author":"ME Katt","year":"2016","unstructured":"Katt ME, Xu ZS, Gerecht S, Searson PC. Human brain microvascular endothelial cells derived from the BC1 iPS cell line exhibit a blood-brain barrier phenotype. PLoS ONE. 2016;11(4): e0152105.","journal-title":"PLoS ONE"},{"issue":"9","key":"347_CR16","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1021\/acs.molpharmaceut.0c00484","volume":"17","author":"RM Linville","year":"2020","unstructured":"Linville RM, DeStefano JG, Nerenberg RF, Grifno GN, Ye R, Gallagher E, Searson PC. Long-term cryopreservation preserves blood-brain barrier phenotype of iPSC-derived brain microvascular endothelial cells and three-dimensional microvessels. Mol Pharm. 2020;17(9):3425\u201334.","journal-title":"Mol Pharm"},{"issue":"6","key":"347_CR17","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stemcr.2019.05.008","volume":"12","author":"EH Neal","year":"2019","unstructured":"Neal EH, Marinelli NA, Shi Y, McClatchey PM, Balotin KM, Gullett DR, Hagerla KA, Bowman AB, Ess KC, Wikswo JP, Lippmann ES, Simplified A. Fully defined differentiation scheme for producing blood-brain barrier endothelial cells from human iPSCs. Stem Cell Reports. 2019;12(6):1380\u20138.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"347_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12987-020-00207-2","volume":"17","author":"DMF Francisco","year":"2020","unstructured":"Francisco DMF, Marchetti L, Rodriguez-Lorenzo S, Frias-Anaya E, Figueiredo RM, Bt RN, Winter P, Romero IA, de Vries HE, Engelhardt B, Bruggmann R. Advancing brain barriers RNA sequencing: guidelines from experimental design to publication. Fluids Barriers CNS. 2020;17(1):51.","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"347_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8): e47.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"347_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"347_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma\u2019ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128.","journal-title":"BMC Bioinform"},{"issue":"1","key":"347_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/jpet.107.121525","volume":"322","author":"SG Summerfield","year":"2007","unstructured":"Summerfield SG, Read K, Begley DJ, Obradovic T, Hidalgo IJ, Coggon S, Lewis AV, Porter RA, Jeffrey P. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J Pharmacol Exp Ther. 2007;322(1):205\u201313.","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2020.104042","volume":"132","author":"RM Linville","year":"2020","unstructured":"Linville RM, Arevalo D, Maressa JC, Zhao N, Searson PC. Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis. Microvasc Res. 2020;132: 104042.","journal-title":"Microvasc Res"},{"key":"347_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biomaterials.2018.10.023","volume":"190\u2013191","author":"RM Linville","year":"2019","unstructured":"Linville RM, DeStefano JG, Sklar MB, Xu Z, Farrell AM, Bogorad MI, Chu C, Walczak P, Cheng L, Mahairaki V, Whartenby KA, Calabresi PA, Searson PC. Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior. Biomaterials. 2019;190\u2013191:24\u201337.","journal-title":"Biomaterials"},{"issue":"1","key":"347_CR25","doi-asserted-by":"publisher","first-page":"13957","DOI":"10.1038\/s41598-019-50193-1","volume":"9","author":"GN Grifno","year":"2019","unstructured":"Grifno GN, Farrell AM, Linville RM, Arevalo D, Kim JH, Gu L, Searson PC. Tissue-engineered blood-brain barrier models via directed differentiation of human induced pluripotent stem cells. Sci Rep. 2019;9(1):13957.","journal-title":"Sci Rep"},{"issue":"1","key":"347_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23(1):37\u201345.","journal-title":"Int Immunopharmacol"},{"key":"347_CR27","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/srep04160","volume":"4","author":"ES Lippmann","year":"2014","unstructured":"Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep. 2014;4:4160.","journal-title":"Sci Rep"},{"key":"347_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201700093","author":"MJ Stebbins","year":"2018","unstructured":"Stebbins MJ, Lippmann ES, Faubion MG, Daneman R, Palecek SP, Shusta EV. Activation of RARalpha, RARgamma, or RXRalpha increases barrier tightness in human induced pluripotent stem cell-derived brain endothelial cells. Biotechnol J. 2018. https:\/\/doi.org\/10.1002\/biot.201700093.","journal-title":"Biotechnol J"},{"key":"347_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12987-016-0030-5","volume":"13","author":"R Patel","year":"2016","unstructured":"Patel R, Alahmad AJ. Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties. Fluids Barriers CNS. 2016;13:6.","journal-title":"Fluids Barriers CNS"},{"key":"347_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12987-015-0007-9","volume":"12","author":"HK Wilson","year":"2015","unstructured":"Wilson HK, Canfield SG, Hjortness MK, Palecek SP, Shusta EV. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells. Fluids Barriers CNS. 2015;12:13.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"347_CR31","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"issue":"4","key":"347_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder P, Cantle JP, Chatzopoulou D, Wang N, Gao F, Al-Ramahi I, Lu XH, Ramos EM, El-Zein K, Zhao Y, Deverasetty S, Tebbe A, Schaab C, Lavery DJ, Howland D, Kwak S, Botas J, Aaronson JS, Rosinski J, Coppola G, Horvath S, Yang XW. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat Neurosci. 2016;19(4):623\u201333.","journal-title":"Nat Neurosci"},{"issue":"5","key":"347_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee H, Fenster RJ, Pineda SS, Gibbs WS, Mohammadi S, Davila-Velderrain J, Garcia FJ, Therrien M, Novis HS, Gao F, Wilkinson H, Vogt T, Kellis M, LaVoie MJ, Heiman M. Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation. Neuron. 2020;107(5):891\u2013908.","journal-title":"Neuron"},{"issue":"7903","key":"347_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41586-022-04521-7","volume":"603","author":"FJ Garcia","year":"2022","unstructured":"Garcia FJ, Sun N, Lee H, Godlewski B, Mathys H, Galani K, Zhou B, Jiang X, Ng AP, Mantero J, Tsai LH, Bennett DA, Sahin M, Kellis M, Heiman M. Single-cell dissection of the human brain vasculature. Nature. 2022;603(7903):893\u20139.","journal-title":"Nature"},{"issue":"8","key":"347_CR35","doi-asserted-by":"publisher","first-page":"e2016950118","DOI":"10.1073\/pnas.2016950118","volume":"118","author":"TM Lu","year":"2021","unstructured":"Lu TM, Houghton S, Magdeldin T, Duran JGB, Minotti AP, Snead A, Sproul A, Nguyen DT, Xiang J, Fine HA, Rosenwaks Z, Studer L, Rafii S, Agalliu D, Redmond D, Lis R. Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate. Proc Natl Acad Sci USA. 2021;118(8):e2016950118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"347_CR36","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","volume":"254","author":"N Klepac","year":"2007","unstructured":"Klepac N, Relja M, Klepac R, Hecimovic S, Babic T, Trkulja V. Oxidative stress parameters in plasma of Huntington\u2019s disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects\u202f: a cross-sectional study. J Neurol. 2007;254(12):1676\u201383.","journal-title":"J Neurol"},{"issue":"2","key":"347_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM, Lee PW, Soong BW, Chiu DT. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Commun. 2007;359(2):335\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"347_CR38","first-page":"9187195","volume":"2020","author":"Q Tang","year":"2020","unstructured":"Tang Q, Liu H, Shi XJ, Cheng Y. Blood oxidative stress marker aberrations in patients with huntington\u2019s disease: a meta-analysis study. Oxid Med Cell Longev. 2020;2020:9187195.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"347_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12974-021-02147-6","volume":"18","author":"GC O'Regan","year":"2021","unstructured":"O\u2019Regan GC, Farag SH, Casey CS, Wood-Kaczmar A, Pocock JM, Tabrizi SJ, Andre R. Human Huntington\u2019s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species. J Neuroinflamm. 2021;18(1):94.","journal-title":"J Neuroinflamm"},{"key":"347_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.524369","volume":"12","author":"E Machiela","year":"2020","unstructured":"Machiela E, Jeloka R, Caron NS, Mehta S, Schmidt ME, Baddeley HJE, Tom CM, Polturi N, Xie Y, Mattis VB, Hayden MR, Southwell AL. The interaction of aging and cellular stress contributes to pathogenesis in mouse and human huntington disease neurons. Front Aging Neurosci. 2020;12: 524369.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"347_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ratan RR. Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly. J Huntingtons Dis. 2016;5(3):217\u201337.","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"347_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41598-018-36769-3","volume":"9","author":"C Anasooya Shaji","year":"2019","unstructured":"Anasooya Shaji C, Robinson BD, Yeager A, Beeram MR, Davis ML, Isbell CL, Huang JH, Tharakan B. The tri-phasic role of hydrogen peroxide in blood-brain barrier endothelial cells. Sci Rep. 2019;9(1):133.","journal-title":"Sci Rep"},{"key":"347_CR43","unstructured":"Munn S, Allanou R, Aschberger K, Berthault F, De BruijnJ, Musset C, O\u2019 Connor S, Pakalin S, Pellegrini G, Scheer S, Vegro S. European Union Risk Assessment Report. Hydrogen Peroxide. 2003."},{"issue":"2","key":"347_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1007049806660","volume":"20","author":"SI Rapoport","year":"2000","unstructured":"Rapoport SI. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol. 2000;20(2):217\u201330.","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"347_CR45","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1177\/0271678X19867980","volume":"40","author":"RM Linville","year":"2020","unstructured":"Linville RM, DeStefano JG, Sklar MB, Chu C, Walczak P, Searson PC. Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels. J Cereb Blood Flow Metab. 2020;40(7):1517\u201332.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"347_CR46","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.stemcr.2020.03.011","volume":"14","author":"LE Oikari","year":"2020","unstructured":"Oikari LE, Pandit R, Stewart R, Cuni-Lopez C, Quek H, Sutharsan R, Rantanen LM, Oksanen M, Lehtonen S, de Boer CM, Polo JM, Gotz J, Koistinaho J, White AR. Altered brain endothelial cell phenotype from a familial alzheimer mutation and its potential implications for amyloid clearance and drug delivery. Stem Cell Rep. 2020;14(5):924\u201339.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"347_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12987-018-0117-2","volume":"15","author":"JG DeStefano","year":"2018","unstructured":"DeStefano JG, Jamieson JJ, Linville RM, Searson PC. Benchmarking in vitro tissue-engineered blood-brain barrier models. Fluids Barriers CNS. 2018;15(1):32.","journal-title":"Fluids Barriers CNS"},{"key":"347_CR48","doi-asserted-by":"crossref","unstructured":"Linville RM, Sklar MB, Grifno GN, Nerenberg RF, Zhou J, Ye R, DeStefano JG, Guo Z, Jha R, Jamieson JJ, Zhao N, Searson PC. Three-dimensional microenvironment regulates gene expression, function, and tight junction dynamics of iPSC-derived blood-brain barrier microvessels, bioRxiv (2021).","DOI":"10.1101\/2021.08.27.457975"},{"issue":"4","key":"347_CR49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"Genetic Modifiers of Huntington's Disease Consortium","year":"2019","unstructured":"Genetic Modifiers of Huntington\u2019s Disease Consortium. CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell. 2019;178(4):887\u2013900.","journal-title":"Cell"},{"issue":"12","key":"347_CR50","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1021\/acs.molpharmaceut.6b00818","volume":"13","author":"JL Mantle","year":"2016","unstructured":"Mantle JL, Min L, Lee KH. Minimum transendothelial electrical resistance thresholds for the study of small and large molecule drug transport in a human in vitro blood-brain barrier model. Mol Pharm. 2016;13(12):4191\u20138.","journal-title":"Mol Pharm"},{"issue":"5","key":"347_CR51","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","volume":"1822","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF. Antioxidants in Huntington\u2019s disease. Biochim Biophys Acta. 2012;1822(5):664\u201374.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"347_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0928-0987(00)00152-4","volume":"12","author":"PJ Gaillard","year":"2000","unstructured":"Gaillard PJ, de Boer AG. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci. 2000;12(2):95\u2013102.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"347_CR53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/0271678X16630991","volume":"36","author":"HC Helms","year":"2016","unstructured":"Helms HC, Abbott NJ, Burek M, Cecchelli R, Couraud PO, Deli MA, Forster C, Galla HJ, Romero IA, Shusta EV, Stebbins MJ, Vandenhaute E, Weksler B, Brodin B. In vitro models of the blood-brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab. 2016;36(5):862\u201390.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"347_CR54","doi-asserted-by":"publisher","first-page":"16693","DOI":"10.1096\/fj.202001507RR","volume":"34","author":"H Nishihara","year":"2020","unstructured":"Nishihara H, Gastfriend BD, Soldati S, Perriot S, Mathias A, Sano Y, Shimizu F, Gosselet F, Kanda T, Palecek SP, Du Pasquier R, Shusta EV, Engelhardt B. Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions. FASEB J. 2020;34(12):16693\u2013715.","journal-title":"FASEB J"},{"issue":"9","key":"347_CR55","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.celrep.2019.02.008","volume":"26","author":"J Ooi","year":"2019","unstructured":"Ooi J, Langley SR, Xu X, Utami KH, Sim B, Huang Y, Harmston NP, Tay YL, Ziaei A, Zeng R, Low D, Aminkeng F, Sobota RM, Ginhoux F, Petretto E, Pouladi MA. Unbiased profiling of isogenic Huntington disease hPSC-Derived CNS and peripheral cells reveals strong cell-type specificity of CAG length effects. Cell Rep. 2019;26(9):2494\u2013508.","journal-title":"Cell Rep"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00347-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T07:05:37Z","timestamp":1656572737000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00347-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}